Skip to main content
Premium Trial:

Request an Annual Quote

Quest to Outfit Labs With Bio-Rad's BioPlex 2200 Platform, HIV Assay

NEW YORK (GenomeWeb News) — Bio-Rad Laboratories today said it will supply Quest Diagnostics with its BioPlex 2200 systems and autoimmune test reagents, as well as its HIV-1/HIV-2 PLUS O EIA assay for use in its reference laboratories nationwide.
 
Terms of the agreements were not released.
 
In early April Bio-Rad announced that it had released Epstein Barr virus kits to run on the BioPlex 2200 system and that it has more than 15 other multiplex reagent kits in development.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.